Home About Cancer News Contact Cancer News
Home About Cancer News Contact Cancer News
Twitter

Archive for June 21st, 2012

« Older Entries

Inflammation, Stress & Social Behavior: Using Ecological Assessments & Model Systems to Enhance Relevance to Health Outcomes

By on Thursday, June 21st, 2012 | No Comments

Condition :   Hepatitis C Intervention :   Drug: Interferon-alpha Sponsors :   University of Arizona;   University of Arizona;   Emory University Recruiting – verified June 2012

Read More...

Study of Alemtuzumab in Treatment Refractory MS Subjects/Alemtuzumab Naive & Alemtuzumab Experienced Subjects

By on Thursday, June 21st, 2012 | No Comments

Condition :   Multiple Sclerosis Interventions :   Drug: Alemtuzumab;   Drug: Alemtuzumab immunotherapy Sponsors :   Advanced Neurosciences Institute;   Samuel Forrester Hunter, MD, PhD Not yet recruiting – verified June 2012

Read More...

Effect of Neurokinin-1 Receptor (NK1R) Antagonism on Pruritus in Patients With Sezary Syndrome

By on Thursday, June 21st, 2012 | No Comments

Conditions :   Sezary Syndrome;   Pruritus Interventions :   Drug: Aprepitant;   Drug: Placebo Sponsors :   Vanderbilt University;   Vanderbilt University Recruiting – verified June 2012

Read More...

Clinical Significance of Circulating Tumor Cells (CTCs) in Blood of Patients With Advanced/Metastatic Gastric Cancer

By on Thursday, June 21st, 2012 | No Comments

Condition :   Gastric Cancer Intervention :   Device: CellSearch® CTC kit Sponsors :   Peking University;   Peking University Active, not recruiting – verified June 2012

Read More...

Phase 1 Safety Study of X-396, an Oral ALK Inhibitor, in Patients With Advanced Solid Tumors

By on Thursday, June 21st, 2012 | No Comments

Condition :   Advanced Solid Tumors Intervention :   Drug: X-396 Sponsors :   Xcovery Holding Company, LLC;   Xcovery Holding Company, LLC Recruiting – verified June 2012

Read More...

Horse ATG in Patients With AA or Low/Int-1 Risk MDS

By on Thursday, June 21st, 2012 | No Comments

Condition :   Leukemia Interventions :   Drug: hATG;   Drug: Cyclosporine;   Drug: Methylprednisone;   Drug: Pegfilgrastim;   Drug: Filgrastim Sponsors :   M.D. Anderson Cancer Center;   M.D. Anderson Cancer Center Not yet recruiting – verified June 2012

Read More...

Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia

By on Thursday, June 21st, 2012 | No Comments

Condition :   Leukemia Interventions :   Genetic: RNA analysis;   Genetic: gene expression analysis;   Genetic: microarray analysis;   Genetic: nucleic acid sequencing;   Genetic: polymerase chain reaction;   Other: laboratory biomarker analysis Sponsors :   National Cancer Institute (NCI);   Children’s Oncology Group;   National Cancer Institute (NCI) Active, not recruiting – verified June 2012

Read More...

Tivantinib and Temsirolimus in Treating Patients With Metastatic or Unresectable Solid Tumors

By on Thursday, June 21st, 2012 | No Comments

Condition :   Unspecified Adult Solid Tumor, Protocol Specific Interventions :   Drug: tivantinib;   Drug: temsirolimus;   Other: pharmacological study;   Other: laboratory biomarker analysis Sponsors :   National Cancer Institute (NCI);   National Cancer Institute (NCI) Recruiting – verified June 2012

Read More...

A Study of CD45RA+ Depleted Haploidentical Stem Cell Transplantation in Children With Relapsed or Refractory Solid Tumors and Lymphomas

By on Thursday, June 21st, 2012 | No Comments

Conditions :   Ewing Sarcoma;   Gastrointestinal Tumor;   Germ Cell Tumor;   Hepatic Tumor;   Lymphoma;   Wilms Tumor;   Rhabdoid Tumor;   Clear Cell Carcinoma;   Renal Cell Carcinoma;   Melanoma;   Neuroblastoma;   Rhabdomyosarcoma;   Non-rhabdomyosarcoma Interventions :   Drug: alemtuzumab;   Drug: fludarabine;   Drug: sirolimus;   Drug: Busulfan;   Drug: melphalan;   Biological: stem cells Sponsors :   St. Jude Children’s Research Hospital;   St. Jude Children’s Research Hospital Not yet recruiting – verified June 2012

Read More...

Neoadjuvant Study of Nab-paclitaxel Plus Carboplatin in Breast Cancer

By on Thursday, June 21st, 2012 | No Comments

Condition :   Breast Cancer Intervention :   Drug: nab-paclitaxel Sponsors :   Shanghai Cancer Hospital,China;   Shanghai Cancer Hospital,China Not yet recruiting – verified June 2012

Read More...
« Older Entries